SIMILAR PATTERNS OF AMINO ACIDS FOR 3NLJ_A_H4BA760_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1a6c | TOBACCO RINGSPOTVIRUS CAPSID PROTEIN (Tobaccoringspot virus) |
PF03391(Nepo_coat)PF03688(Nepo_coat_C)PF03689(Nepo_coat_N) | 4 | VAL A 496ARG A 482VAL A 390PHE A 374 | None | 1.24A | 3nljA-1a6cA:0.03nljB-1a6cA:0.0 | 3nljA-1a6cA:20.383nljB-1a6cA:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1b41 | ACETYLCHOLINESTERASE (Homo sapiens) |
PF00135(COesterase) | 4 | VAL A 326ARG A 219VAL A 209PHE A 222 | None | 1.13A | 3nljA-1b41A:0.03nljB-1b41A:0.0 | 3nljA-1b41A:20.793nljB-1b41A:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1c2o | ACETYLCHOLINESTERASE (Electrophoruselectricus) |
PF00135(COesterase) | 4 | VAL A 326ARG A 219VAL A 209PHE A 222 | None | 1.01A | 3nljA-1c2oA:0.03nljB-1c2oA:0.0 | 3nljA-1c2oA:20.213nljB-1c2oA:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1c4k | PROTEIN (ORNITHINEDECARBOXYLASE) (Lactobacillussp. 30A) |
PF01276(OKR_DC_1)PF03709(OKR_DC_1_N)PF03711(OKR_DC_1_C) | 4 | VAL A 667TRP A 673PHE A 681GLU A 649 | None | 1.26A | 3nljA-1c4kA:0.03nljB-1c4kA:0.0 | 3nljA-1c4kA:19.203nljB-1c4kA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ccz | PROTEIN (CD58) (Homo sapiens) |
PF05790(C2-set) | 4 | VAL A 92ARG A 52VAL A 13GLU A 72 | None | 0.92A | 3nljA-1cczA:0.03nljB-1cczA:0.0 | 3nljA-1cczA:17.723nljB-1cczA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1edz | 5,10-METHYLENETETRAHYDROFOLATEDEHYDROGENASE (Saccharomycescerevisiae) |
PF00763(THF_DHG_CYH)PF02882(THF_DHG_CYH_C) | 4 | VAL A 120VAL A 114PHE A 42GLU A 121 | None | 1.18A | 3nljA-1edzA:0.73nljB-1edzA:0.0 | 3nljA-1edzA:22.273nljB-1edzA:22.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1em8 | DNA POLYMERASE IIICHI SUBUNIT (Escherichiacoli) |
PF04364(DNA_pol3_chi) | 4 | VAL A 21ARG A 130VAL A 114PHE A 6 | None | 1.25A | 3nljA-1em8A:0.03nljB-1em8A:0.0 | 3nljA-1em8A:18.053nljB-1em8A:18.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1flg | PROTEIN(QUINOPROTEINETHANOLDEHYDROGENASE) (Pseudomonasaeruginosa) |
PF01011(PQQ)PF13360(PQQ_2) | 4 | VAL A 41TRP A 521PHE A 501GLU A 519 | None | 1.23A | 3nljA-1flgA:0.03nljB-1flgA:0.0 | 3nljA-1flgA:19.843nljB-1flgA:19.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1hqo | URE2 PROTEIN (Saccharomycescerevisiae) |
PF00043(GST_C)PF02798(GST_N) | 4 | VAL A 334VAL A 299TRP A 337GLU A 260 | None | 1.05A | 3nljA-1hqoA:0.53nljB-1hqoA:0.9 | 3nljA-1hqoA:19.283nljB-1hqoA:19.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mfa | IGG1-LAMBDA SE155-4FAB (LIGHT CHAIN) (Mus musculus) |
PF07686(V-set) | 4 | VAL L 108ARG L 63VAL L 18GLU L 85 | None | 1.22A | 3nljA-1mfaL:undetectable3nljB-1mfaL:undetectable | 3nljA-1mfaL:14.223nljB-1mfaL:14.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mzb | FERRIC UPTAKEREGULATION PROTEIN (Pseudomonasaeruginosa) |
PF01475(FUR) | 4 | ARG A 69VAL A 54PHE A 79GLU A 36 | None | 1.16A | 3nljA-1mzbA:undetectable3nljB-1mzbA:undetectable | 3nljA-1mzbA:16.593nljB-1mzbA:16.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nfd | H57 FAB (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL E 106ARG E 61VAL E 19GLU E 83 | None | 0.99A | 3nljA-1nfdE:undetectable3nljB-1nfdE:undetectable | 3nljA-1nfdE:18.933nljB-1nfdE:18.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1pw3 | IMMUNOGLOBULINLAMBDA CHAINVARIABLE REGION (Homo sapiens) |
PF07686(V-set) | 4 | VAL A 106ARG A 61VAL A 19GLU A 83 | None | 0.85A | 3nljA-1pw3A:undetectable3nljB-1pw3A:undetectable | 3nljA-1pw3A:13.953nljB-1pw3A:13.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t5r | LUKS-PV (Staphylococcusphage PVL) |
PF07968(Leukocidin) | 4 | VAL A 193VAL A 202PHE A 163GLU A 197 | None | 1.23A | 3nljA-1t5rA:undetectable3nljB-1t5rA:undetectable | 3nljA-1t5rA:20.663nljB-1t5rA:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wql | ETHYLBENZENEDIOXYGENASE SMALLSUBUNIT (Pseudomonasfluorescens) |
PF00866(Ring_hydroxyl_B) | 4 | ARG B 156VAL B 128PHE B 163GLU B 26 | None | 1.23A | 3nljA-1wqlB:undetectable3nljB-1wqlB:undetectable | 3nljA-1wqlB:19.793nljB-1wqlB:19.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1xn6 | HYPOTHETICAL PROTEINBC4709 (Bacillus cereus) |
PF08327(AHSA1) | 4 | VAL A 27VAL A 140TRP A 36PHE A 16 | None | 1.08A | 3nljA-1xn6A:undetectable3nljB-1xn6A:undetectable | 3nljA-1xn6A:15.333nljB-1xn6A:15.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1z9m | GAPA225 (Homo sapiens) |
PF07686(V-set) | 4 | VAL A 136ARG A 92VAL A 56GLU A 115 | None | 1.06A | 3nljA-1z9mA:undetectable3nljB-1z9mA:undetectable | 3nljA-1z9mA:17.613nljB-1z9mA:17.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a9m | FLUORESCEIN-SCFVLIGHT CHAIN (Homo sapiens) |
PF07686(V-set) | 4 | VAL L 147ARG L 77VAL L 19GLU L 101 | None | 0.94A | 3nljA-2a9mL:undetectable3nljB-2a9mL:undetectable | 3nljA-2a9mL:13.743nljB-2a9mL:13.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b39 | C3 (Bos taurus) |
PF00207(A2M)PF01759(NTR)PF01821(ANATO)PF01835(A2M_N)PF07677(A2M_recep)PF07678(A2M_comp)PF07703(A2M_N_2)PF10569(Thiol-ester_cl) | 4 | ARG A 708VAL A1424PHE A 722GLU A 693 | None | 1.10A | 3nljA-2b39A:undetectable3nljB-2b39A:undetectable | 3nljA-2b39A:13.743nljB-2b39A:13.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d4e | 5-CARBOXYMETHYL-2-HYDROXYMUCONATESEMIALDEHYDEDEHYDROGENASE (Thermusthermophilus) |
PF00171(Aldedh) | 4 | VAL A 326VAL A 294PHE A 321GLU A 327 | None | 1.16A | 3nljA-2d4eA:undetectable3nljB-2d4eA:undetectable | 3nljA-2d4eA:23.193nljB-2d4eA:23.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fja | ADENYLYLSULFATEREDUCTASE, SUBUNIT A (Archaeoglobusfulgidus) |
PF00890(FAD_binding_2)PF02910(Succ_DH_flav_C) | 4 | ARG A 586VAL A 578TRP A 579GLU A 555 | None | 1.23A | 3nljA-2fjaA:undetectable3nljB-2fjaA:undetectable | 3nljA-2fjaA:22.293nljB-2fjaA:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2inc | TOLUENE, O-XYLENEMONOOXYGENASEOXYGENASE SUBUNIT (Pseudomonasstutzeri) |
PF02332(Phenol_Hydrox)PF04945(YHS) | 4 | VAL A 23ARG A 116PHE A 29GLU A 27 | None | 1.12A | 3nljA-2incA:0.03nljB-2incA:undetectable | 3nljA-2incA:21.483nljB-2incA:21.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jvo | NUCLEOLAR PROTEIN 3 (Saccharomycescerevisiae) |
PF00076(RRM_1) | 4 | VAL A 43VAL A 61PHE A 52GLU A 47 | None | 1.14A | 3nljA-2jvoA:undetectable3nljB-2jvoA:undetectable | 3nljA-2jvoA:13.863nljB-2jvoA:13.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nxf | PUTATIVE DIMETALPHOSPHATASE (Danio rerio) |
PF00149(Metallophos) | 4 | VAL A 52ARG A 311VAL A 44PHE A 296 | EOH A 502 (-4.7A)NoneNoneNone | 1.16A | 3nljA-2nxfA:0.23nljB-2nxfA:undetectable | 3nljA-2nxfA:22.593nljB-2nxfA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ot9 | HYPOTHETICAL PROTEIN (Pseudomonassyringae groupgenomosp. 3) |
PF07152(YaeQ) | 4 | VAL A 152ARG A 179VAL A 170PHE A 49 | None | 1.26A | 3nljA-2ot9A:undetectable3nljB-2ot9A:undetectable | 3nljA-2ot9A:19.073nljB-2ot9A:19.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2qyt | 2-DEHYDROPANTOATE2-REDUCTASE (Porphyromonasgingivalis) |
PF02558(ApbA)PF08546(ApbA_C) | 4 | VAL A 296VAL A 287PHE A 238GLU A 236 | None | 1.24A | 3nljA-2qytA:undetectable3nljB-2qytA:undetectable | 3nljA-2qytA:23.133nljB-2qytA:23.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rhe | BENCE-JONES PROTEINRHE (LIGHT CHAIN) (Homo sapiens) |
PF07686(V-set) | 4 | VAL A 109ARG A 62VAL A 18GLU A 84 | None | 1.04A | 3nljA-2rheA:undetectable3nljB-2rheA:undetectable | 3nljA-2rheA:14.773nljB-2rheA:14.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3aw9 | NAD-DEPENDENTEPIMERASE/DEHYDRATASE (Pyrobaculumcalidifontis) |
PF01370(Epimerase) | 4 | VAL A 206VAL A 228TRP A 285GLU A 207 | None | 1.20A | 3nljA-3aw9A:undetectable3nljB-3aw9A:undetectable | 3nljA-3aw9A:20.753nljB-3aw9A:20.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bjl | LOC - LAMBDA 1 TYPELIGHT-CHAIN DIMER (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL A 109ARG A 62VAL A 18GLU A 84 | None | 1.11A | 3nljA-3bjlA:undetectable3nljB-3bjlA:undetectable | 3nljA-3bjlA:21.093nljB-3bjlA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h0g | DNA-DIRECTED RNAPOLYMERASE IISUBUNIT RPB2 (Schizosaccharomycespombe) |
PF00562(RNA_pol_Rpb2_6)PF04560(RNA_pol_Rpb2_7)PF04561(RNA_pol_Rpb2_2)PF04563(RNA_pol_Rpb2_1)PF04565(RNA_pol_Rpb2_3)PF04566(RNA_pol_Rpb2_4)PF04567(RNA_pol_Rpb2_5) | 4 | VAL B 685ARG B 590VAL B 602GLU B 682 | None | 1.21A | 3nljA-3h0gB:0.53nljB-3h0gB:undetectable | 3nljA-3h0gB:15.453nljB-3h0gB:15.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3iy4 | FRAGMENT OFNEUTRALIZINGANTIBODY 15 (HEAVYCHAIN) (Mus musculus) |
PF07686(V-set) | 4 | VAL B 221ARG B 172VAL B 123PHE B 173 | None | 1.19A | 3nljA-3iy4B:undetectable3nljB-3iy4B:undetectable | 3nljA-3iy4B:13.033nljB-3iy4B:13.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kxa | PUTATIVEUNCHARACTERIZEDPROTEIN (Neisseriagonorrhoeae) |
PF01381(HTH_3) | 4 | VAL A 114VAL A 105PHE A 65GLU A 118 | None | 1.04A | 3nljA-3kxaA:undetectable3nljB-3kxaA:undetectable | 3nljA-3kxaA:17.403nljB-3kxaA:17.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lrh | ANTI-HUNTINGTIN VLDOMAIN (Homo sapiens) |
PF07686(V-set) | 4 | VAL A 109ARG A 62VAL A 18GLU A 84 | None | 0.86A | 3nljA-3lrhA:undetectable3nljB-3lrhA:undetectable | 3nljA-3lrhA:17.273nljB-3lrhA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mj9 | JUNCTIONAL ADHESIONMOLECULE-LIKE (Mus musculus) |
PF07686(V-set) | 4 | VAL A 118ARG A 70VAL A 21GLU A 94 | None | 1.04A | 3nljA-3mj9A:undetectable3nljB-3mj9A:undetectable | 3nljA-3mj9A:21.263nljB-3mj9A:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3owc | PROBABLEACETYLTRANSFERASE (Pseudomonasaeruginosa) |
PF00583(Acetyltransf_1) | 4 | ARG A 175VAL A 92PHE A 121GLU A 119 | None | 1.19A | 3nljA-3owcA:undetectable3nljB-3owcA:undetectable | 3nljA-3owcA:17.113nljB-3owcA:17.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p30 | 1281 FAB LIGHT CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL L 106ARG L 61VAL L 19GLU L 83 | None | 0.76A | 3nljA-3p30L:undetectable3nljB-3p30L:undetectable | 3nljA-3p30L:19.953nljB-3p30L:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qaw | RHO-CLASSGLUTATHIONES-TRANSFERASE (Laternulaelliptica) |
PF00043(GST_C)PF13417(GST_N_3) | 4 | VAL A 85ARG A 199VAL A 24PHE A 161 | None | 1.17A | 3nljA-3qawA:undetectable3nljB-3qawA:undetectable | 3nljA-3qawA:20.193nljB-3qawA:20.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r4z | GLYCOSYL HYDROLASEFAMILY 32, NTERMINAL (Saccharophagusdegradans) |
PF04616(Glyco_hydro_43) | 4 | VAL A 130VAL A 94TRP A 66GLU A 129 | None | 1.23A | 3nljA-3r4zA:undetectable3nljB-3r4zA:undetectable | 3nljA-3r4zA:20.813nljB-3r4zA:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ri5 | MOUSE MONOCLONAL FABFRAGMENT, LIGHTCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL K 108ARG K 63VAL K 18GLU K 85 | None | 1.15A | 3nljA-3ri5K:undetectable3nljB-3ri5K:undetectable | 3nljA-3ri5K:19.193nljB-3ri5K:19.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3t2n | ANTIBODY, FABFRAGMENT, LIGHTCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL L 106ARG L 61VAL L 19GLU L 83 | None | 0.83A | 3nljA-3t2nL:undetectable3nljB-3t2nL:undetectable | 3nljA-3t2nL:20.153nljB-3t2nL:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ux9 | SCFV ANTIBODY (Homo sapiens) |
PF07686(V-set) | 4 | VAL B 111ARG B 64VAL B 20GLU B 86 | None | 1.05A | 3nljA-3ux9B:undetectable3nljB-3ux9B:undetectable | 3nljA-3ux9B:21.183nljB-3ux9B:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vv4 | METHYL-ACCEPTINGCHEMOTAXIS PROTEIN (Thermosynechococcuselongatus) |
PF01590(GAF) | 4 | VAL A 72TRP A 71PHE A 67GLU A 73 | NonePVG A 201 (-3.6A)NoneNone | 1.01A | 3nljA-3vv4A:0.33nljB-3vv4A:undetectable | 3nljA-3vv4A:19.243nljB-3vv4A:19.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zl4 | A17 ANTIBODY FABFRAGMENT LAMBDALIGHT CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL L 108ARG L 62VAL L 18GLU L 84 | None | 0.98A | 3nljA-3zl4L:undetectable3nljB-3zl4L:undetectable | 3nljA-3zl4L:19.533nljB-3zl4L:19.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zog | FMN-BINDING PROTEIN (Pyrococcushorikoshii) |
PF01613(Flavin_Reduct) | 4 | VAL A 132VAL A 41PHE A 61GLU A 112 | None | 1.13A | 3nljA-3zogA:undetectable3nljB-3zogA:undetectable | 3nljA-3zogA:17.953nljB-3zogA:17.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b90 | DIHYDROPYRIMIDINASE-RELATED PROTEIN 5 (Homo sapiens) |
PF01979(Amidohydro_1) | 4 | VAL A 110ARG A 150VAL A 154GLU A 144 | None | 1.09A | 3nljA-4b90A:0.13nljB-4b90A:undetectable | 3nljA-4b90A:20.483nljB-4b90A:20.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b92 | DIHYDROPYRIMIDINASE-RELATED PROTEIN 5 (Homo sapiens) |
PF01979(Amidohydro_1) | 4 | VAL A 110ARG A 150VAL A 154GLU A 144 | None | 1.12A | 3nljA-4b92A:undetectable3nljB-4b92A:undetectable | 3nljA-4b92A:22.163nljB-4b92A:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4de8 | CPS2A (Streptococcuspneumoniae) |
PF02916(DNA_PPF)PF03816(LytR_cpsA_psr) | 4 | VAL A 347VAL A 350PHE A 360GLU A 335 | None | 1.16A | 3nljA-4de8A:2.03nljB-4de8A:undetectable | 3nljA-4de8A:22.173nljB-4de8A:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dfi | POLIOVIRUSRECEPTOR-RELATEDPROTEIN 2 (Homo sapiens) |
PF07686(V-set) | 4 | VAL A 128ARG A 72VAL A 20GLU A 105 | None | 1.00A | 3nljA-4dfiA:undetectable3nljB-4dfiA:undetectable | 3nljA-4dfiA:14.763nljB-4dfiA:14.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4eq5 | DNA LIGASE (Thermococcussibiricus) |
PF01068(DNA_ligase_A_M)PF04675(DNA_ligase_A_N)PF04679(DNA_ligase_A_C) | 4 | VAL A 214ARG A 200VAL A 193GLU A 218 | None | 0.85A | 3nljA-4eq5A:undetectable3nljB-4eq5A:undetectable | 3nljA-4eq5A:20.543nljB-4eq5A:20.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fmf | POLIOVIRUSRECEPTOR-RELATEDPROTEIN 1 (Homo sapiens) |
PF07686(V-set)PF08205(C2-set_2)PF13927(Ig_3) | 4 | VAL A 142ARG A 96VAL A 47GLU A 119 | None | 1.01A | 3nljA-4fmfA:undetectable3nljB-4fmfA:undetectable | 3nljA-4fmfA:21.403nljB-4fmfA:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fmk | POLIOVIRUSRECEPTOR-RELATEDPROTEIN 2 (Mus musculus) |
PF07686(V-set)PF08205(C2-set_2) | 4 | VAL A 149ARG A 97VAL A 50GLU A 126 | None | 1.01A | 3nljA-4fmkA:undetectable3nljB-4fmkA:undetectable | 3nljA-4fmkA:21.803nljB-4fmkA:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4glr | ANTI-PTAU LIGHTCHAIN (Gallus gallus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL I 106ARG I 61VAL I 19GLU I 83 | None | 1.15A | 3nljA-4glrI:undetectable3nljB-4glrI:undetectable | 3nljA-4glrI:19.083nljB-4glrI:19.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k3g | IMMUNOGLOBULINLAMBDA VARIABLEDOMAIN L5(L89S) (Homo sapiens) |
PF07686(V-set) | 4 | VAL A 106ARG A 61VAL A 19GLU A 83 | None | 1.24A | 3nljA-4k3gA:undetectable3nljB-4k3gA:undetectable | 3nljA-4k3gA:14.863nljB-4k3gA:14.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l37 | ARYLPHORIN (Bombyx mori) |
PF00372(Hemocyanin_M)PF03722(Hemocyanin_N)PF03723(Hemocyanin_C) | 4 | VAL B 351TRP B 355PHE B 327GLU B 424 | None | 1.00A | 3nljA-4l37B:undetectable3nljB-4l37B:undetectable | 3nljA-4l37B:20.833nljB-4l37B:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l95 | GAMMA-GLUTAMYLHYDROLASE (Danio rerio) |
no annotation | 4 | VAL E 45VAL E 249PHE E 37GLU E 39 | None | 1.07A | 3nljA-4l95E:undetectable3nljB-4l95E:0.0 | 3nljA-4l95E:19.103nljB-4l95E:19.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m2x | DIHYDROFOLATEREDUCTASE (Mycobacteriumtuberculosis) |
PF00186(DHFR_1) | 4 | VAL A 79ARG A 61VAL A 41GLU A 84 | None | 1.15A | 3nljA-4m2xA:undetectable3nljB-4m2xA:undetectable | 3nljA-4m2xA:17.093nljB-4m2xA:17.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o6x | ANKYRIN-3 (Homo sapiens) |
PF00531(Death) | 4 | VAL A 71ARG A 58PHE A 28GLU A 25 | None | 1.12A | 3nljA-4o6xA:undetectable3nljB-4o6xA:undetectable | 3nljA-4o6xA:14.693nljB-4o6xA:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4o9h | LIGHT CHAIN OF THECAMELID FAB FRAGMENT61H7 (Lama glama) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL L 108ARG L 63VAL L 18GLU L 85 | None | 1.21A | 3nljA-4o9hL:undetectable3nljB-4o9hL:undetectable | 3nljA-4o9hL:20.153nljB-4o9hL:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ouo | ANTI BLA G 1 SCFV (Gallus gallus) |
PF07686(V-set) | 4 | VAL A 106ARG A 60VAL A 18GLU A 82 | None | 1.13A | 3nljA-4ouoA:undetectable3nljB-4ouoA:undetectable | 3nljA-4ouoA:20.283nljB-4ouoA:20.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p49 | ANTIBODY SCFV B8 (Gallus gallus) |
PF07686(V-set) | 4 | VAL A 101ARG A 56VAL A 16GLU A 78 | None | 1.22A | 3nljA-4p49A:undetectable3nljB-4p49A:undetectable | 3nljA-4p49A:21.783nljB-4p49A:21.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p5w | CALCIUM-BINDINGMITOCHONDRIALCARRIER PROTEINARALAR2,CALCIUM-BINDING MITOCHONDRIALCARRIER PROTEINARALAR2 (Homo sapiens) |
no annotation | 4 | VAL A 264VAL A 255PHE A 273GLU A 268 | None | 1.18A | 3nljA-4p5wA:undetectable3nljB-4p5wA:undetectable | 3nljA-4p5wA:20.913nljB-4p5wA:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rnr | PGT130 LIGHT CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 106ARG B 61VAL B 19GLU B 83 | None | 1.00A | 3nljA-4rnrB:undetectable3nljB-4rnrB:undetectable | 3nljA-4rnrB:19.393nljB-4rnrB:19.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4u3v | POLYKETIDE SYNTHASEPKSR (Bacillussubtilis) |
PF14765(PS-DH) | 4 | VAL A 19TRP A 140PHE A 144GLU A 139 | None | 1.03A | 3nljA-4u3vA:undetectable3nljB-4u3vA:undetectable | 3nljA-4u3vA:20.813nljB-4u3vA:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4unu | IG LAMBDA CHAIN V-IIREGION MGC (Homo sapiens) |
PF07686(V-set) | 4 | VAL A 109ARG A 63VAL A 18GLU A 85 | None | 0.96A | 3nljA-4unuA:undetectable3nljB-4unuA:undetectable | 3nljA-4unuA:13.923nljB-4unuA:13.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4v1d | SINGLE CHAINANTIBODY FRAGMENTRU1, LIGHT CHAIN (Homo sapiens) |
PF07686(V-set) | 4 | VAL E 248ARG E 201VAL E 157GLU E 223 | None | 1.03A | 3nljA-4v1dE:undetectable3nljB-4v1dE:undetectable | 3nljA-4v1dE:14.763nljB-4v1dE:14.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xj5 | CYCLIC AMP-GMPSYNTHASE (Vibrio cholerae) |
no annotation | 4 | ARG A 280VAL A 309TRP A 267PHE A 268 | None | 1.13A | 3nljA-4xj5A:undetectable3nljB-4xj5A:undetectable | 3nljA-4xj5A:20.613nljB-4xj5A:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xj6 | VC0179-LIKE PROTEIN (Escherichiacoli) |
no annotation | 4 | ARG A 276VAL A 305PHE A 264GLU A 266 | None | 1.07A | 3nljA-4xj6A:undetectable3nljB-4xj6A:undetectable | 3nljA-4xj6A:21.063nljB-4xj6A:21.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xj6 | VC0179-LIKE PROTEIN (Escherichiacoli) |
no annotation | 4 | VAL A 305TRP A 263PHE A 264GLU A 266 | None | 1.11A | 3nljA-4xj6A:undetectable3nljB-4xj6A:undetectable | 3nljA-4xj6A:21.063nljB-4xj6A:21.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4y5x | DIABODY 310 VHDOMAIN (Homo sapiens) |
PF07686(V-set) | 4 | VAL B 109ARG B 62VAL B 18GLU B 84 | None | 0.85A | 3nljA-4y5xB:undetectable3nljB-4y5xB:undetectable | 3nljA-4y5xB:14.453nljB-4y5xB:14.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yfa | PROTEIN RELATED TOPENICILLIN ACYLASE (Acidovorax sp.MR-S7) |
PF01804(Penicil_amidase) | 4 | VAL C 335VAL C 511TRP C 550GLU C 338 | None | 1.12A | 3nljA-4yfaC:undetectable3nljB-4yfaC:undetectable | 3nljA-4yfaC:21.463nljB-4yfaC:21.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yjz | SCFV H2526 (Homo sapiens) |
PF07686(V-set) | 4 | VAL L 109ARG L 62VAL L 18GLU L 84 | None | 1.09A | 3nljA-4yjzL:undetectable3nljB-4yjzL:undetectable | 3nljA-4yjzL:21.743nljB-4yjzL:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zs7 | LLAMA FAB FRAGMENT68F2 LIGHT CHAIN (Lama glama) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL L 109ARG L 63VAL L 18GLU L 85 | None | 1.10A | 3nljA-4zs7L:undetectable3nljB-4zs7L:undetectable | 3nljA-4zs7L:19.353nljB-4zs7L:19.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5exe | OXALATEOXIDOREDUCTASESUBUNIT ALPHA (Moorellathermoacetica) |
PF01855(POR_N)PF17147(PFOR_II) | 4 | VAL A 363VAL A 279PHE A 372GLU A 367 | None | 0.99A | 3nljA-5exeA:undetectable3nljB-5exeA:undetectable | 3nljA-5exeA:22.253nljB-5exeA:22.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6h | DH427 ANTIBODY LIGHTCHAIN (Macaca mulatta) |
no annotation | 4 | VAL L 109ARG L 63VAL L 18GLU L 85 | None | 0.97A | 3nljA-5f6hL:undetectable3nljB-5f6hL:undetectable | 3nljA-5f6hL:21.123nljB-5f6hL:21.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fcs | DIABODY (Homo sapiens) |
PF07686(V-set) | 4 | VAL H 108ARG H 63VAL H 18GLU H 85 | None | 1.19A | 3nljA-5fcsH:undetectable3nljB-5fcsH:undetectable | 3nljA-5fcsH:18.633nljB-5fcsH:18.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fcs | DIABODY (Homo sapiens) |
PF07686(V-set) | 4 | VAL L 109ARG L 62VAL L 18GLU L 84 | NoneSO4 L 304 ( 4.9A)NoneNone | 0.91A | 3nljA-5fcsL:undetectable3nljB-5fcsL:undetectable | 3nljA-5fcsL:19.953nljB-5fcsL:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fcu | JR4 FAB LIGHT CHAIN (Macaca mulatta) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL L 106ARG L 61VAL L 19GLU L 83 | NoneSO4 L 303 (-3.9A)NoneSO4 L 301 ( 4.5A) | 1.04A | 3nljA-5fcuL:undetectable3nljB-5fcuL:undetectable | 3nljA-5fcuL:19.543nljB-5fcuL:19.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hhx | CAT-2000 FAB LIGHTCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL L 106ARG L 61VAL L 19GLU L 83 | None | 1.05A | 3nljA-5hhxL:undetectable3nljB-5hhxL:undetectable | 3nljA-5hhxL:20.093nljB-5hhxL:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ihz | 1E01 FAB FRAGMENTLIGHT CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL B 126ARG B 75VAL B 19GLU B 99 | None | 1.00A | 3nljA-5ihzB:undetectable3nljB-5ihzB:undetectable | 3nljA-5ihzB:19.863nljB-5ihzB:19.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ilt | BOVINE FAB A01 LIGHTCHAIN (Bos taurus) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL L 106ARG L 61VAL L 19GLU L 83 | None | 0.95A | 3nljA-5iltL:undetectable3nljB-5iltL:undetectable | 3nljA-5iltL:19.863nljB-5iltL:19.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ir3 | IG LAMBDA CHAIN V-VIREGION AR (Homo sapiens) |
PF07686(V-set) | 4 | VAL A 110ARG A 62VAL A 18GLU A 86 | None | 1.14A | 3nljA-5ir3A:undetectable3nljB-5ir3A:undetectable | 3nljA-5ir3A:14.703nljB-5ir3A:14.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5j74 | SCFV AM2.2 (Homo sapiens) |
PF07686(V-set) | 4 | VAL A 251ARG A 204VAL A 160GLU A 226 | None | 0.96A | 3nljA-5j74A:undetectable3nljB-5j74A:undetectable | 3nljA-5j74A:19.953nljB-5j74A:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jo5 | 10E8 GLV (Homo sapiens) |
no annotation | 4 | VAL L 106ARG L 61VAL L 19GLU L 83 | None | 1.10A | 3nljA-5jo5L:undetectable3nljB-5jo5L:undetectable | 3nljA-5jo5L:18.853nljB-5jo5L:18.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jse | PHIAB6 TAILSPIKE (unidentifiedphage) |
PF12708(Pectate_lyase_3) | 4 | VAL A 341TRP A 323TRP A 347PHE A 290 | None | 1.16A | 3nljA-5jseA:undetectable3nljB-5jseA:undetectable | 3nljA-5jseA:21.693nljB-5jseA:21.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5l6q | H5AL (Homo sapiens) |
PF07686(V-set) | 4 | VAL A 106ARG A 59VAL A 17GLU A 81 | NoneNoneNone ZN A 203 (-2.5A) | 1.20A | 3nljA-5l6qA:undetectable3nljB-5l6qA:undetectable | 3nljA-5l6qA:15.013nljB-5l6qA:15.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5m8t | 5,6-DIHYDROXYINDOLE-2-CARBOXYLIC ACIDOXIDASE (Homo sapiens) |
PF00264(Tyrosinase) | 4 | ARG A 225TRP A 414PHE A 411GLU A 413 | None | 1.01A | 3nljA-5m8tA:undetectable3nljB-5m8tA:undetectable | 3nljA-5m8tA:20.213nljB-5m8tA:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mes | LIGHT CHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | VAL L 109ARG L 62VAL L 18GLU L 84 | None | 1.00A | 3nljA-5mesL:undetectable3nljB-5mesL:undetectable | 3nljA-5mesL:20.003nljB-5mesL:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n2k | BRIAKINUMAB FABLIGHT CHAIN (Homo sapiens) |
no annotation | 4 | VAL G 110ARG G 62VAL G 18GLU G 84 | None | 1.12A | 3nljA-5n2kG:undetectable3nljB-5n2kG:undetectable | 3nljA-5n2kG:11.813nljB-5n2kG:11.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ocy | ACPA E4 FAB FRAGMENT- LIGHT CHAIN (Homo sapiens) |
no annotation | 4 | VAL L 109ARG L 62VAL L 18GLU L 84 | None | 0.87A | 3nljA-5ocyL:undetectable3nljB-5ocyL:undetectable | 3nljA-5ocyL:16.843nljB-5ocyL:16.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5t4z | ANTIBODY DH501 FABLIGHT CHAIN (Macaca mulatta) |
no annotation | 4 | VAL L 106ARG L 61VAL L 19GLU L 83 | None | 1.02A | 3nljA-5t4zL:undetectable3nljB-5t4zL:undetectable | 3nljA-5t4zL:19.753nljB-5t4zL:19.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ukn | DH522UCA FABFRAGMENT LIGHT CHAIN (Macaca mulatta) |
no annotation | 4 | VAL L 106ARG L 61VAL L 19GLU L 83 | None | 0.97A | 3nljA-5uknL:undetectable3nljB-5uknL:undetectable | 3nljA-5uknL:12.253nljB-5uknL:12.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vf6 | SINGLE CHAINVARIABLE FRAGMENT (Gallus gallus) |
no annotation | 4 | VAL A 104ARG A 58VAL A 16GLU A 80 | None | 1.13A | 3nljA-5vf6A:undetectable3nljB-5vf6A:undetectable | 3nljA-5vf6A:11.113nljB-5vf6A:11.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vyo | THIOL:DISULFIDEINTERCHANGE PROTEIN (Burkholderiapseudomallei) |
no annotation | 4 | VAL A 57TRP A 56PHE A 49GLU A 54 | None | 1.09A | 3nljA-5vyoA:0.43nljB-5vyoA:undetectable | 3nljA-5vyoA:12.503nljB-5vyoA:12.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wdu | BNAB 35O22 FAB LIGHTCHAIN (Homo sapiens) |
no annotation | 4 | VAL I 106ARG I 61VAL I 19GLU I 83 | None | 1.14A | 3nljA-5wduI:undetectable3nljB-5wduI:undetectable | 3nljA-5wduI:11.913nljB-5wduI:11.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x5w | NECTIN-1 (Sus scrofa) |
PF07686(V-set) | 4 | VAL B 106ARG B 60VAL B 11GLU B 83 | None | 1.04A | 3nljA-5x5wB:undetectable3nljB-5x5wB:undetectable | 3nljA-5x5wB:12.833nljB-5x5wB:12.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xcv | VL-SARAH(S37C)CHIMERA,VL-SARAH(S37C) CHIMERA (Homo sapiens;Rattus) |
no annotation | 4 | VAL B 106ARG B 61VAL B 19GLU B 83 | None | 0.99A | 3nljA-5xcvB:undetectable3nljB-5xcvB:undetectable | 3nljA-5xcvB:16.363nljB-5xcvB:16.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xf7 | PROTEINDISULFIDE-ISOMERASE-LIKE PROTEIN OF THETESTIS (Homo sapiens) |
no annotation | 4 | ARG A 129VAL A 65PHE A 113GLU A 106 | None | 1.17A | 3nljA-5xf7A:undetectable3nljB-5xf7A:undetectable | 3nljA-5xf7A:10.853nljB-5xf7A:10.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xgp | SECRETED XWNT8INHIBITOR SIZZLED (Xenopus laevis) |
PF01392(Fz) | 4 | VAL A 254TRP A 224PHE A 180GLU A 222 | None | 0.89A | 3nljA-5xgpA:undetectable3nljB-5xgpA:undetectable | 3nljA-5xgpA:19.913nljB-5xgpA:19.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xyi | 40S RIBOSOMALPROTEIN S5-B,PUTATIVEUNCHARACTERIZEDPROTEIN (Trichomonasvaginalis) |
PF00177(Ribosomal_S7)PF00333(Ribosomal_S5)PF03719(Ribosomal_S5_C) | 4 | VAL c 16ARG F 49PHE F 50GLU c 51 | None C 21421 ( 4.4A)NoneNone | 1.09A | 3nljA-5xyic:undetectable3nljB-5xyic:undetectable | 3nljA-5xyic:11.363nljB-5xyic:11.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yfg | RAN GUANINENUCLEOTIDE RELEASEFACTOR (Homo sapiens) |
no annotation | 4 | VAL A 85VAL A 82PHE A 68GLU A 61 | None | 1.24A | 3nljA-5yfgA:undetectable3nljB-5yfgA:undetectable | 3nljA-5yfgA:16.823nljB-5yfgA:16.82 |